Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 5,414 shares at $42.45 ($232K) on 2019-01-02, disclosed to the SEC on 2019-01-04.
Open-market sale of $232k XLRN by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.45 | 2,363 | $100K | 43.2% |
| 2 | $43.20 | 3,051 | $132K | 56.8% |
| Total | $42.87 avg | 5,414 | $232K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $132K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |
| XLRN | SELL | 2017-09-14 | $176K | — | Filing → |